Refine Results
- Country
- Language
- Application
1 - 8 of 8 results
Webinars
Stay connected with the latest product introductions and applications, as well as software enhancements, with Agilent’s live or recorded webinars. These technical one- and two-hour events are a convenient way to keep your knowledge up to date on the latest technologies and learn from industry professionals. Sign up to receive email notifications when new webinars are posted.Applied Filters
xCELLigence RTCA- impedance biosensors to continuously monitor changes in cell number, cell morphology, cell-substrate attachment strength, and cell barrier function. Track the same population of cells via three-color live cell imaging.
The rate of cellular ATP production is a powerful and straightforward measurement of energy metabolism. This webinar will discuss how OCR and ECAR can be easily converted into rates of mitochondrial and glycolytic ATP production. This routine method...
Dr. John Connolly, Tessa Therapeutics, will present a novel flow cytometry-based method to demonstrate the importance of metabolic change in memory T cell differentiation, highlight these factors as attributes of adoptive T cell therapy.
Dr. Yuting Sun discusses her research supporting a Phase 1 clinical trial advancing cancer therapies, targeted at metabolic vulnerabilities. Strategies in targeting two metabolic vulnerabilities-FHmut cancer and glycolysis-deficient cancer.
Leukemia is a cancer of the body's blood-forming tissues, including bone marrow (Acute myeloid leukemia-AML) and the lymphatic system (Acute lymphatic leukemia-ALL). From a metabolic perspective, acquired chemoresistance is associated with a shift...
This webinar assesses the Seahorse XF platform as a tool for screening mitochondrial dysfunction and presents a workflow with reference to a panel of mitochondrial toxic drugs.
Introducing the XF Substrate Oxidation Stress Tests, a robust portfolio of XF assays enabling insights into cellular substrate dependencies to identify specific mitochondrial substrates that are relevant for cellular phenotype and function.
Dr. David Ferrick discusses how advances in our understanding of T cell co-receptors have led to new strategies for keeping immune cells turned on in the suppressive, hostile tumor microenvironment.